(NASDAQ: ASTH) Astrana Health's forecast annual revenue growth rate of 26.91% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 4.43%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.83%.
Astrana Health's revenue in 2025 is $2,250,574,000.On average, 4 Wall Street analysts forecast ASTH's revenue for 2025 to be $178,983,182,348, with the lowest ASTH revenue forecast at $177,056,341,307, and the highest ASTH revenue forecast at $180,294,465,792. On average, 4 Wall Street analysts forecast ASTH's revenue for 2026 to be $227,487,607,386, with the lowest ASTH revenue forecast at $221,112,998,299, and the highest ASTH revenue forecast at $235,163,745,178.
In 2027, ASTH is forecast to generate $243,476,015,216 in revenue, with the lowest revenue forecast at $243,476,015,216 and the highest revenue forecast at $243,476,015,216.